M&A Deal Summary

KV Pharmaceutical Acquires Hologic - Gestiva

On January 22, 2008, KV Pharmaceutical acquired life science company Hologic - Gestiva from Hologic for 82M USD

Acquisition Highlights
  • This is KV Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is KV Pharmaceutical’s largest (disclosed) transaction.
  • This is KV Pharmaceutical’s 1st transaction in the United States.

M&A Deal Summary

Date 2008-01-22
Target Hologic - Gestiva
Sector Life Science
Buyer(s) KV Pharmaceutical
Sellers(s) Hologic
Deal Type Divestiture
Deal Value 82M USD

Target

Hologic - Gestiva

United States
Hologic - Gestiva is a drug, which could be used in the prevention of preterm birth in pregnant women with a history of at least one spontaneous preterm birth.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

KV Pharmaceutical

Chesterfield, Missouri, United States

Category Company
Sector Life Science
DESCRIPTION

KV Pharmaceutical Co. engages in development, manufacturer, acquires and markets branded and generic/non-branded prescription pharmaceutical products.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-09-21 KV Pharmaceutical - ANDA

Chesterfield, Missouri, United States

KV Pharmaceutical - ANDA comprises clindamycin phosphate (1%) and benzoyl peroxide (5%) gel. Duac gel, indicated for the topical treatment of inflammatory acne vulgaris.

Sell $14M

Seller(S) 1

SELLER

Hologic

Marlborough, Massachusetts, United States

Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.0B USD (2023)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.


DEAL STATS #
Overall 1 of 4
Sector (Life Science) 1 of 2
Type (Divestiture) 1 of 4
Country (United States) 1 of 4
Year (2008) 1 of 1
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-22 Cytyc

Marlborough, Massachusetts, United States

Cytyc Corp, is a design, development, manufacture, and marketing of clinical products that focus on women’s health.

Buy $6.2B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-06-09 Third Wave Technologies

Madison, Wisconsin, United States

Third Wave Technologies, Inc. is a developer and marketer of molecular diagnostic reagents for a wide variety of DNA and RNA analysis applications based on its proprietary Invader chemistry. The company's current clinical diagnostic offerings consist of products for conditions such as Cystic Fibrosis, Hepatitis C, cardiovascular risk and other diseases.

Buy $580M